Should I still go to treatment?
Currently, the American Society of Clinical Oncology (ASCO) states that “at this time, there is no specific evidence or published guidance to support delaying or interrupting adjuvant chemotherapy
As of today, the only treatment ASCO is recommending for the potential delay (especially if your disease is currently under control) is for a planned allogeneic stem cell transplant. Donors may need to be screened for COVID-19 prior to collection as well. Patients with stable disease who are considering autologous stem cell transplant should also talk to their team about a potential delay in this procedure. The European Society for Blood and Marrow Transplantation (EMBT) is recommending delay of transplant procedures for at least three months.